Helicobacter pylori eradication in patients on long-term H2 receptor antagonists. Economic and symptomatic benefits. A large prospective study in primary care.

@article{Verma2002HelicobacterPE,
  title={Helicobacter pylori eradication in patients on long-term H2 receptor antagonists. Economic and symptomatic benefits. A large prospective study in primary care.},
  author={Sumita Verma and Mustafa H Giaffer},
  journal={Helicobacter},
  year={2002},
  volume={7 2},
  pages={91-8}
}
BACKGROUND A large proportion of patients in primary care are still being maintained on long-term acid suppression, without any attempts to identify Helicobacter pylori status and to treat those that test positive. OBJECTIVES To assess the prevalence and economic and symptomatic benefits of H. pylori eradication in patients maintained on long-term H2 receptor antagonists (H2RA) in primary care. PATIENTS AND METHODS Patients on long-term (i.e. 6 months or longer) H2RA were identified from… CONTINUE READING